SEC Filings

Form 10-Q
ZOMEDICA PHARMACEUTICALS CORP. filed this Form 10-Q on 05/10/2019
Document Outline
Entire Document (2845.5 KB)
Subdocument 1 - 10-Q - FORM 10-Q
Page 1 - UNITED STATES
Page 2 - N/A
Page 3 - Zomedica Pharmaceuticals Corporation
Page 4 - PART I FINANCIAL INFORMATION
Page 5 - Zomedica Pharmaceuticals Corp.
Page 6 - Zomedica Pharmaceuticals Corp.
Page 7 - Zomedica Pharmaceuticals Corp.
Page 8 - 1. Nature of operations and going concern
Page 9 - 1. Nature of operations and going concern (continued)
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - 13. Financial instruments (continued)
Page 21 - N/A
Page 22 - For the above-mentioned periods, the Company had securities outstanding which could potentially dilu
Page 23 - Item 2. MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
Page 24 - Overview
Page 25 - Revenue
Page 26 - General and Administrative Expense
Page 27 - Use of Estimates
Page 28 - Loss Per Share
Page 29 - N/A
Page 30 - Cash Flows
Page 31 - Liquidity and Capital Resources
Page 32 - Off Balance Sheet Arrangements
Page 33 - Item 3. Quantitative and Qualitative Disclosures About Market Risk.
Page 34 - Item 1A. Risk Factors.
Page 35 - Risks Related to Our Securities
Page 36 - In the event of a sale of our company, holders of our Series 1 Preferred Shares will be entitled to
Page 37 - Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Page 38 - Item 3. Defaults Upon Senior Securities.
Page 39 - SIGNATURES
Page 40 - EXHIBIT INDEX
Subdocument 2 - EX-3.5 - EXHIBIT 3.5
Page 1 - Exhibit 3.5
Page 2 - SCHEDULE TO THE ARTICLES OF AMENDMENT OF
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Subdocument 3 - EX-10.29 - EXHIBIT 10.29
Page 1 - Exhibit 10.29
Page 2 - Incoming Canadian $ wires:
Page 3 - PLEASE DELIVER THE AFOREMENTIONED DOCUMENTS TO:
Page 4 - TERMS AND CONDITIONS OF SUBSCRIPTION FOR
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - Unless permitted under securities legislation, the holder of this security must not trade the securi
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - PRIVACY NOTICE
Page 14 - TSX VENTURE EXCHANGE APPENDIX 6A
Page 15 - SCHEDULE A
Page 16 - IMPORTANT
Page 17 - EXHIBIT A TO SCHEDULE A
Page 18 - [Note: Financial assets include cash and securities, but do not include a personal residence see the
Page 19 - Note: If you initialled (t), then indicate the name and category of accredited investor (by referenc
Page 20 - PLEASE MARK YOUR INITIALS BESIDE THE CATEGORY ABOVE TO WHICH YOU BELONG
Page 21 - N/A
Page 22 - EXHIBIT B TO SCHEDULE A
Page 23 - Form instructions:
Page 24 - SCHEDULE B
Page 25 - Interpretive Aids
Page 26 - SCHEDULE C
Page 27 - You are buying Exempt Market Securities
Page 28 - SCHEDULE D
Page 29 - N/A
Page 30 - Form instructions:
Page 31 - SCHEDULE E
Page 32 - N/A
Page 33 - SCHEDULE F
Page 34 - N/A
Page 35 - N/A
Page 36 - N/A
Page 37 - N/A
Page 38 - N/A
Page 39 - SCHEDULE G
Page 40 - N/A
Page 41 - SCHEDULE H
Page 42 - THIS IS NOT A PUBLIC DOCUMENT
Subdocument 4 - EX-31.1 - EXHIBIT 31.1
Page 1 - N/A
Subdocument 5 - EX-31.2 - EXHIBIT 31.2
Page 1 - N/A
Subdocument 6 - EX-32.1 - EXHIBIT 32.1
Page 1 - N/A
XBRL Item - EX-101.INS - XBRL INSTANCE FILE (What's this?)
XBRL Item - EX-101.SCH - XBRL SCHEMA FILE (What's this?)
XBRL Item - EX-101.CAL - XBRL CALCULATION FILE (What's this?)
XBRL Item - EX-101.DEF - XBRL DEFINITION FILE (What's this?)
XBRL Item - EX-101.LAB - XBRL LABEL FILE (What's this?)
XBRL Item - EX-101.PRE - XBRL PRESENTATION FILE (What's this?)
XBRL Viewer